IRAK1 downregulation can inhibit the activation of the MAPKs/NLRP3/IL-1β signaling pathway, preventing the proliferation, migration, and invasion of HCC cells (Chen et al., 2020). The gene discussed is NLRP3; the disease is hepatocellular carcinoma.